News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,120 Results
Type
Article (42547)
Company Profile (288)
Press Release (661285)
Section
Business (209422)
Career Advice (2898)
Deals (36250)
Drug Delivery (88)
Drug Development (82456)
Employer Resources (178)
FDA (16659)
Job Trends (15429)
News (354161)
Policy (33728)
Tag
Academia (2718)
Africa (844)
Alliances (50582)
Alzheimer's disease (1197)
Approvals (16585)
Arizona (188)
Artificial intelligence (89)
Asia (38293)
Australia (6374)
Bankruptcy (362)
Best Places to Work (11833)
Biosimilars (68)
Biotechnology (203)
Breast cancer (79)
C2C Services and Suppliers (81953)
California (2156)
Canada (1018)
Cancer (651)
Career advice (2424)
Cell therapy (162)
China (168)
Clinical research (64804)
Collaboration (205)
Colorado (90)
Compensation (115)
Connecticut (92)
COVID-19 (2584)
Cystic fibrosis (81)
Data (481)
Diabetes (101)
Diagnostics (6262)
Drug pricing (81)
Earnings (84993)
Employer resources (153)
Europe (83625)
Events (112054)
Executive appointments (193)
FDA (16975)
Florida (315)
Funding (190)
Gene therapy (111)
Georgia (70)
GLP-1 (555)
Government (4576)
Healthcare (19801)
Hotbed/Location (493203)
Illinois (297)
Indiana (158)
Infectious disease (2626)
Inflammatory bowel disease (99)
Interviews (497)
IPO (16564)
Job creations (3791)
Job search strategy (2072)
Kansas (95)
Layoffs (423)
Legal (8139)
Lung cancer (130)
Manufacturing (113)
Maryland (451)
Massachusetts (1799)
Medical device (13640)
Medtech (13645)
Mergers & acquisitions (19598)
Metabolic disorders (302)
Michigan (136)
Minnesota (233)
Neuroscience (1391)
New Jersey (666)
New York (677)
NextGen Class of 2024 (6988)
Non-profit (4861)
North Carolina (650)
Northern California (934)
Obesity (183)
Ohio (117)
Opinion (196)
Patents (80)
Pennsylvania (636)
People (58020)
Phase I (20040)
Phase II (28495)
Phase III (21421)
Pipeline (140)
Postmarket research (2616)
Preclinical (8458)
Radiopharmaceuticals (241)
Rare diseases (159)
Real estate (6077)
Regulatory (22098)
Research institute (2443)
Resumes & cover letters (466)
South America (1236)
Southern California (868)
Startups (3698)
Texas (283)
United States (9752)
Vaccines (512)
Washington State (271)
Weight loss (148)
Date
Today (60)
Last 7 days (675)
Last 30 days (2730)
Last 365 days (37636)
2024 (28252)
2023 (41114)
2022 (52269)
2021 (56934)
2020 (55780)
2019 (48829)
2018 (36956)
2017 (33254)
2016 (32836)
2015 (38840)
2014 (32443)
2013 (27368)
2012 (29651)
2011 (30255)
2010 (28390)
704,120 Results for "option care inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Strenge Spine Center Launches Cutting-Edge Spine Care Solutions
Strenge Spine Center, a pioneering provider of advanced spine care, is proud to announce the launch of its state-of-the-art technologies and innovative treatment options, including the EOSedge system.
June 25, 2024
·
3 min read
Press Releases
Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Boosted by CARES-310 Leading Overall Survival Analysis
September 23, 2024
·
5 min read
Biotech Beach
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Avidity Biosciences, Inc. announced that it has closed its previously announced underwritten public offering of 12,132,500 shares of its common stock, including 1,582,500 shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, at a price to the public of $38.00 per share.
June 17, 2024
·
4 min read
Biotech Beach
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
RxSight, Inc. announced that it has closed its underwritten public offering of 2,053,571 shares of its common stock, at a price to the public of $56.00 per share, which includes the full exercise by the underwriters of their option to purchase up to 267,857 additional shares.
May 13, 2024
·
2 min read
Drug Development
BioLab Holdings, Inc. to Begin Clinical Trials for Wound Care Product
August 22, 2024
·
3 min read
DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at BofA Securities 2024 Health Care Conference on Tuesday, May 14th, 2024 at 5:00 pm Pacific Daylight Time.
May 9, 2024
·
1 min read
BioMidwest
Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference
Inspire Medical Systems, Inc. announced that its management team will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024.
April 30, 2024
·
1 min read
Intellipharmaceutics International Inc. Announces Stock Option Grant - February 08, 2024
Intellipharmaceutics International Inc. announces that, the Company has issued 1,910,000 common share purchase options pursuant to the Company’s stock option plan.
February 8, 2024
·
4 min read
Deals
Option Care Health Confirms Termination of Merger Agreement with Amedisys
Option Care Health, Inc. announced that it has terminated its previously announced agreement to combine with Amedisys, Inc.
June 26, 2023
·
4 min read
BioMidwest
Neuromod’s FDA-Approved Lenire Device Now a Treatment Option for 2.9 Million US Veterans with Tinnitus
Neuromod USA Inc. has been awarded a Federal Supply Schedule 65 II Medical Equipment and Supply Contract from the US Government, making the Lenire tinnitus device a treatment option for the 2.9 million US Veterans living with tinnitus5 through the Department of Veterans Affairs (VA).
June 17, 2024
·
4 min read
1 of 70,412
Next
